Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2021-12-17 to 2022-01-11
Current total value of award: $8109.16
Description: 4555795238!TYSABRI 300 MG/15 ML VIAL 15ML